NCT03536234 - Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 19, 2018

Primary Completion Date

August 31, 2021

Study Completion Date

December 31, 2021

Conditions

HIV-1-infection

Interventions

DRUG

Triptorelin acetate depot

3.75 mg triptorelin depot (monthly injections). 3 doses in total

Trial Locations (5)

RECRUITING

Zentrum für Infektiologie Berlin Prenzlauer Berg, Berlin

RECRUITING

MVZ Karlsplatz, Munich

RECRUITING

Östra sjukhuset, Gothenburg

RECRUITING

Södersjukhuset, Stockholm

RECRUITING

Karolinska University Hospital Huddinge, Stockholm